20476 ⎘
Medicinal preparations containing organic active ingredients; Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
Methods of Treating Amyotrophic Lateral Sclerosis and Symptoms
#302NEW MEDICAL TREATMENT
#303Inhibitors of spore germination
#304COMPOSITIONS AND METHODS FOR THE TREATMENT OF MYELIN RELATED AND INFLAMMATION RELATED DISEASES OR DISORDERS
#305OMEGA MURICHOLIC ACID AS A PREGNANE X RECEPTOR LIGAND FOR TREATING HEPATO-INTESTINAL DISEASES
#306PHYTOECDYSONES AND DERIVATIVES THEREOF FOR USE IN TREATING DISORDERED RESPIRATORY FUNCTION ON VIRAL INFECTION
#307DOSING PROTOCOLS AND REGIMENS FOR AMINOSTEROL TREATMENT
#308HUMAN AMINOSTEROL ENT-03 COMPOUNDS, RELATED COMPOSITIONS COMPRISING THE SAME, AND METHODS OF USING THE SAME
#309STEROIDAL NITRONE F2 FOR USE IN THE PREVENTION AND/OR TREATMENT OF PERMANENT CEREBRAL ISCHAEMIA
#310Tripartite Modulators of Endosomal G Protein-Coupled Receptors
#311PHARMACEUTICAL COMPOSITION COMPRISING 3-BETA-HYDROXY-5-ALPHA-PREGNAN-20-ONE WITH IMPROVED STORAGE AND SOLUBILITY PROPERTIES
#312PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF NONALCOHOLIC STEATOHEPATITIS
#313USE OF A GROUP OF MARKERS FOR DIAGNOSING AND ADJUSTING TREATMENT OF PRIMARY BILIARY CHOLANGITIS, PHARMACEUTICAL COMPOSITION AND SOLID DOSAGE FORM FOR TREATING PRIMARY BILIARY CHOLANGITIS
#314Compositions and methods for treating CNS disorders
#315ORAL COMPOSITIONS WITH IMPROVED BIOAVAILABILITY AND METHODS OF MAKING THE SAME
#316IBAT inhibitors for the treatment of liver diseases
#317COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS AND POTENTIATION OF ANTIBIOTICS
#318TREATMENT AND PREVENTION OF CAPILLARY MALFORMATION-ARTERIOVENOUS MALFORMATION
#319Combination therapies and methods of use thereof for treating cancer
#320Methods and composition for induction of immune response
#321USE OF BILE ACIDS AND DERIVATIVES THEREOF IN PREPARATION OF GPR39 AGONIST
#322Methods and uses of microbiome compositions, components, or metabolites for treating neurodegenerative diseases
#323INTRAVENOUS FORMULATIONS OF RK-33
#324Pharmaceutical compositions and methods of treating cardiovascular diseases
#325METHODS AND COMPOSITIONS FOR STIMULATION AND ENHANCEMENT OF REGENERATION OF TISSUES
#326USE OF FXR AGONISTS FOR TREATING AN INFECTION BY HEPATITIS D VIRUS
#327Compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25HC3S) or pharmaceutically acceptable salt thereof and at least one cyclic oligosaccharide
#328Composition for preventing or treating keloid
#329USE OF TERPENOIDS IN THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES
#330URSODEOXYCHOLIC ACID-CONTAINING AGENT FOR TREATING OR PREVENTING PRESBYOPIA
#331NEW THERAPY
#332TAILORED LIPOSOMES FOR THE TREATMENT OF BACTERIAL INFECTIONS
#333CELL SURFACE ANCHORING ANTIGEN CONJUGATES TO TREAT CANCER
#334METHOD FOR ADMINISTRATION OF URSODEOXYCHOLIC ACID
#335COMPOSITIONS AND METHODS FOR GENERATION OF SINOATRIAL NODE-LIKE CELLS AND THEIR USE IN DRUG DISCOVERY
#336Compositions and methods for the repair of myelin
#337METHODS OF INDUCING OR ENHANCING FARNESOID X RECEPTOR (FXR)-MEDIATED TRANSCRIPTIONAL RESPONSE
#338USE OF MEMBRANE INHIBITORS TO ENHANCE VACCINE DEVELOPMENT AGAINST ENVELOPED VIRUSES
#339Compositions and methods for the treatment and prophylaxis of surgical site infections
#340COMPOSITION FOR PREVENTING OR TREATING DIABETES MELLITUS
#341Treatment of submental fat
#342COMPOSITION AND METHOD FOR TREATMENT OF DIABETES
#343Compositions and methods of clostridiodides difficile treatment, decolonization, and prevention
#344INJECTABLE COMPOSITIONS OF URSODEOXYCHOLIC ACID
#345TREATMENT OF ALCOHOLIC HEPATITIS
#346METHODS OF DEFINING FUNCTIONAL CHANGE AND SLOWING PROGRESSION IN CHRONIC LIVER DISEASE
#347TREATMENT FOR FIBROSIS AND INHIBITION OF FIBROSIS
#348METHODS OF TREATING LIPEDEMA INCLUDING AKR1C1 AS A THERAPEUTIC TARGET
#349BILE ACID RECYCLING INHIBITORS AND SATIOGENS FOR TREATMENT OF DIABETES, OBESITY, AND INFLAMMATORY GASTROINTESTINAL CONDITIONS
#350COMPOSITION FOR PREVENTING OR TREATING METABOLIC LIVER DISEASE
#351Cultivation of human noroviruses
#352TREATMENT COMPRISING FXR AGONISTS
#353LIPOSOMAL TROPONOID COMPOUND FORMULATIONS
#354TREATMENT COMPRISING THE USE OF FXR AGONISTS
#355CBD COMPOSITION
#356COMPOSITION FOR PREVENTING, TREATING, OR AMELIORATING VIRAL INFECTION DISEASE, CONTAINING ACTIVE OXYGEN PRODUCTION INHIBITOR AND ACTIVE OXYGEN SCAVENGER COMPLEX AS ACTIVE INGREDIENTS
#357SMALL-MOLECULAR ADJUVANTS AND IMPLEMENTATIONS THEREOF
#358COMPOSITION COMPRISING STEROL DERIVATIVES FOR USE IN THE TREATMENT OF A NEURONAL PATHOLOGY RELATED TO HYPOXIA, HYPOGLYCEMIA AND/OR HYPERGLYCEMIA
#359METHODS FOR REDUCING TUMOR PROGRESSION AND FIBROSIS AND INCREASING ADAPTIVE IMMUNITY IN MALIGNANCIES
#360PEDIATRIC FORMULATION
#361PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER
#362COMPOSITIONS FOR THE TREATMENT OF CONDITIONS BY DERMAL FILLERS
#363COMPOUNDS FOR USE IN THE TREATMENT OF LIVER DISEASE
#364PHARMACEUTICAL COMPOSITIONS FOR COMBINATION THERAPY
#365PHARMACEUTICAL COMPOSITIONS FOR COMBINATION THERAPY
#366METHODS OF TREATING BILE ACID DIARRHEA
#367COMPOSITIONS FOR THE TREATMENT OF GASTROINTESTINAL INFLAMMATION
#368BILE ACID DERIVATIVE, COMPOSITION AND APPLICATION THEREOF
#369COMBINATION
#370COMBINATION TREATMENT OF LIVER DISEASES USING FXR AGONISTS
#371COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF ALZHEIMER'S DISEASE
#372Insoluble active substance carrier comprising transfersome
#373Optimizing Mifepristone Absorption
#374METHOD FOR DECREASING ADVERSE-EFFECTS OF INTERFERON
#375METHODS AND USES FOR MODULATING BILE ACID HOMEOSTASIS AND TREATMENT OF BILE ACID DISORDERS AND DISEASES
#37625-HYDROXYCHOLESTEROL (25HC), CRYAB AGGREGATION INHIBITOR, IS A NOVEL SENOLYTIC
#377PHARMACEUTICAL COMPOSITION CONTAINING BREXANOLONE, GANAXOLONE, OR ZURANOLONE, AND USE THEREOF
#378COMPOSITIONS COMPRISING FUSIDIC ACID AND PACKAGES THEREFOR
#379CELLULAR SENESCENCE ACTIVATING COMPOUNDS
#380Methods and compositions for the treatment of IL13Ra2—overexpressing cancer
#381THIOL AND DISULFIDE-CONTAINING AGENTS FOR INCREASING MEIBOMIAN GLAND LIPID SECRETION
#382PHARMACEUTICAL COMPOSITIONS COMPRISING A FXR AGONIST AND A FIBRATE FOR USE IN THE TREATMENT OF CHOLESTATIC LIVER DISEASE
#383Compositions and methods for treating CNS disorders
#384METHODS AND COMPOSITIONS FOR STIMULATION OF THE INTESTINAL ENTEROENDOCRINE SYSTEM FOR TREATING DISEASES OR CONDITIONS RELATED TO THE SAME
#385COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS
#386Bile acids and use in disease treatment
#387CENTRAL NERVOUS SYSTEM HEALTH SUPPLEMENT
#388METHODS OF USING OBETICHOLIC ACID
#389Pharmaceutical compositions and methods of treating cardiovascular diseases
#390FORMULATIONS INHIBITING SARS-CoV-2 VIRUS
#391COMPOSITIONS, METHODS FOR REGULATING UTERINE, PLACENTAL GROWTH
#392COMPOSITIONS HAVING THE ABILITY TO PROMOTE HEALTHY CHOLESTEROL LEVELS
#393COMPOSITIONS COMPRISING OXYGENATED CHOLESTEROL SULFATE AND AT LEAST ONE OF POLYALKYLENE GLYCOL, CARBOXYMETHYL CELLULOSE AND POLYOXYLGLYCERIDE
#394CANCER THERAPY
#395Liquid depot for non-invasive sustained delivery of agents to the eye
#396Compositions for improving cell viability and methods of use thereof
#397PHYTOECDYSONES AND THE DERIVATIVES THEREOF FOR USE IN THE TREATMENT OF NEUROMUSCULAR DISEASES
#398COMPOSITIONS COMPRISING BIOLOGICALLY ACTIVE AGENTS AND BILE SALTS
#399Application of a bile acid composite bacterial agent in the preparation of feed additives for mutton sheep
#400PHYTOECDYSONES AND THE DERIVATIVES THEREOF FOR USE IN THE TREATMENT OF IMPAIRED LUNG FUNCTION
#401METHODS AND COMPOSITIONS FOR TREATING VARIOUS DISORDERS
#402METHODS AND COMPOSITIONS FOR TREATING VARIOUS DISORDERS
#403METHODS AND COMPOSITIONS FOR TREATING VARIOUS DISORDERS
#404METHODS AND COMPOSITIONS FOR TREATING VARIOUS DISORDERS
#405METHODS AND COMPOSITIONS FOR TREATING VARIOUS DISORDERS
#406METHODS AND COMPOSITIONS FOR TREATING VARIOUS DISORDERS
#407METHODS AND COMPOSITIONS FOR TREATING VARIOUS DISORDERS
#408METHODS AND COMPOSITIONS FOR TREATING VARIOUS DISORDERS
#409APPLICATION OF GLYCOCHOLIC ACID IN PREPARATION OF ANTITUMOR DRUGS
#410Oxindoles and methods of use thereof
#411Cannabinoid pouches
#412TUNABLE ENDOGENOUS PROTEIN DEGRADATION
#413Reconstituted high density lipoprotein formulation and production method thereof
#414Methods and compositions related to glucocorticoid receptor antagonists and breast cancer
#415COMPOSITIONS OF OBETICHOLIC ACID AND METHODS OF USE
#416COMPOSITION OF LANOSTEROL PRODRUG COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF
#417Topical treatment of wounds with statins and cholesterol for scar reduction
#418Biologically active ganoderma lucidum compounds and synthesis of anticancer derivatives; ergosterol peroxide probes for cellular localization
#419Blend of Plant-Extracted Oils
#420Compositions of bile acids and phenylbutyrate compounds
#421COMPOSITIONS FOR IMPROVING CELL VIABILITY AND METHODS OF USE THEREOF
#422COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF NEUROLOGICAL DISORDERS
#423METHODS AND COMPOSITIONS FOR TREATING INTESTINAL DISORDER
#424METHOD AND PHARMACOLOGICAL COMPOSITION FOR THE PREVENTION OF RECURRENT INFECTIONS CAUSED BY CLOSTRIDIUM DIFFICILE
#425Ursodeoxycholic acid-containing agent for treating or preventing presbyopia
#426Concomitant administration of glucocorticoid receptor modulators and CYP3A inhibitors
#427TAILORED LIPOSOMES FOR THE TREATMENT OF BACTERIAL INFECTIONS
#428MAINTENANCE OF AGING MUSCLE TISSUE
#429COMPOSITION FOR PREVENTING OR TREATING LIVER DISEASES
#430URSODEOXYCHOLIC ACID-CONTAINING AGENT FOR TREATING OR PREVENTING PRESBYOPIA
#431TREATMENTS OF ACCUMULATED FAT WITH DEOXYCHOLIC ACID AND SALTS THEREOF
#432COMPOSITION AND METHOD FOR TREATMENT OF DIABETES
#433TRANSDERMAL CANCER ANTIGEN PEPTIDE PREPARATION
#434Edible blended vegetable oil for reducing blood lipids and cholesterol
#435Use of glucocorticoid receptor antagonists in combination with glucocorticoids to treat adrenal insufficiency
#436Treatment for primary biliary cholangitis
#437Immunoregulatory agent
#438Sulfated-Oxysterol and Oxysterol Sulfation by Hydroxysterol Sulfotransferase Promote Lipid Homeostasis and Liver Tissue Regeneration
#439Compositions and methods for enhanced delivery of antiviral agents
#440COMPOSITIONS COMPRISING CANNABIDIOL AND SECOND THERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER
#441COMPOSITION AND METHOD FOR TREATMENT OF DIABETES
#442Inactivating bacteria with electric pulses and antibiotics
#443Topical Lipolysis Composition and Methods
#444Aramchol salts
#445Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction
#446Methods and compositions for the treatment of cytoplasmic glycogen storage disorders
#447METHODS FOR MONITORING TREATMENT OF CHRONIC LIVER DISEASE
#448Skin barrier composition
#449Methods for attenuating graft-versus-host disease and opportunistic infections
#450Formulations for epidermal repair
#451METHODS AND COMPOUNDS FOR MODULATING THE SECRETION OR EXPRESSION OF ADHESION PROTEINS OR ANGIOPOIETINS OF CELLS
#452METHODS OF ACTIVATING MICROGLIAL CELLS
#453STABLE FORMULATIONS OF ANESTHETICS AND ASSOCIATED DOSAGE FORMS
#454Pharmaceutical composition to treat health conditions associated with elevated glucose levels
#455PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF CYSTIC FIBROSIS
#456SYNTHETIC DERIVATIVES OF CHOLIC ACID 7-SULFATE AND USES THEREOF
#457COMPOSITIONS AND METHODS FOR THE TREATMENT OF LIVER DISORDERS
#458MULTI-LAYERED PARTICLES
#459CYCLODEXTRIN DIMERS AND USES THEREOF
#460Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction
#461COMPOSITION FOR INCREASING BIOLOGICAL ACTIVITY OF STEM CELLS USING MIXTURE 4F
#462PREPARATION AND USES OF OBETICHOLIC ACID
#463Small molecule-mediated restoration of airway surface physiology in human cystic fibrosis lung epithelia
#464THE APPLICATION OF URSODEOXYCHOLIC ACID OR ITS PHARMACEUTICAL SALT IN THE PREPARATION OF AN ANTITUMOR DRUG AND AN ANTITUMOR DRUG
#465COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY BOWEL DISEASE, CONTAINING, AS ACTIVE INGREDIENT, TAURODEOXYCHOLIC ACID OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
#466TOPICAL FORMULATIONS COMPRISING A STEROID
#467Use of cationic steroidal antimicrobial compounds to deactivate coronavirus
#468COMBINATION TREATMENT OF LIVER DISORDERS
#469COMBINATION TREATMENT OF LIVER DISORDERS
#470PROSTATE FUNCTION SUPPORT FORMULA
#471Composition for prevention or treatment of allergic disease including inotodiol compound as active ingredient
#472PHYTOECDYSONES FOR USE IN THE PREVENTION OF MUSCLE STRENGTH LOSS DURING IMMOBILISATION
#473ANTIMICROBIAL DRUG METHODS OF USE & THERAPEUTIC COMPOSITIONS
#474Treatment of endometriosis by intravaginal administration of a low dose of a selective progesterone receptor modulator (SPRM), anti-progestin, or anti-progestational agent
#475LIPID COMPOSITION CONTAINING MICRONUTRIENTS FOR THE PREVENTION AND/OR TREATMENT OF METABOLIC DISEASES
#476Methods of treating SARS-CoV-2 infections
#477Steroid compounds as Treg modulators and uses thereof
#478STEROL PURIFICATION
#479REGULATOR OF TGR5 SIGNALING AS IMMUNOMODULATORY AGENT
#480TREATMENT OF FIBROSIS USING FXR LIGANDS
#481ALPHA POLYGLUTAMATED TETRAHYDROFOLATES AND USES THEREOF
#482CANNABINOID POUCHES
#483IBAT inhibitors for the treatment of liver diseases
#484Combination therapy for the treatment of liver disease
#485METHODS FOR TREATING SLEEP DISORDERS, SLEEP DISTURBANCES, AND RELATED SYMPTOMS USING AMINOSTEROL COMPOSITIONS
#486COMPOUNDS AND METHODS FOR PREVENTION AND TREATMENT OF CORONAVIRUS INFECTIONS
#487COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF NEURODEGENERATIVE DISEASES
#488COMPOSITIONS AND METHODS FOR ENHANCED DELIVERY OF ANTIVIRAL AGENTS
#489ANTIBACTERIAL COMBINATIONS
#490AZOLE COMOPUND OPHTHALMIC PREPARATION
#491Compositions for treating CMT and related disorders
#492RESPIRATORY TREATMENTS USING SALMONID OIL COMPOSITIONS
#493Compositions and methods related to cholic acid 7-sulfate as a treatment for diabetes
#494COMPOSITIONS AND METHODS FOR TREATING BRAIN-GUT DISORDERS
#495STABLE PHARMACEUTICAL COMPOSITIONS FOR PRESSURIZED METERED DOSE INHALERS
#496Composition of a drug carrier, pharmaceutical composition thereof, preparation method and use method thereof
#497TARGETED PROTEIN DEGRADATION TO ATTENUATE ADOPTIVE T-CELL THERAPY ASSOCIATED ADVERSE INFLAMMATORY RESPONSES
#498Fluorinated bile acid derivatives
#499Composition for modulating intestinal permeability and/or treating and/or preventing leaky gut related diseases, and method for modulating intestinal permeability and/or treating and/or preventing leaky gut related diseases
#500Composition and method for promoting normal urinary function
#501LIPID EMULSION FOR PARENTERAL ADMINISTRATION
#502USE OF MYOSTATIN INHIBITORS AND COMBINATION THERAPIES
#503TUMOR REDUCTION FORMULATIONS AND METHODS OF USE THEREOF
#504LOW DOSAGE INTRANASAL AMINOSTEROL DOSAGE FORMS AND METHODS OF USING THE SAME
#505Therapy for Inflammatory Linear Verrucous Epidermal Nevus (ILVEN)
#506TREATMENT OF SEPSIS AND SEPTIC SHOCK
#507METHODS AND COMPOSITIONS FOR TREATING AND/OR PREVENTING THE PROGRESSION AND/OR ONSET OF AGE-RELATED NEURODEGENERATION
#508COMPOSITION FOR THE PREVENTION OR THE TREATMENT OF VISUAL IMPAIRMENTS COMPRISING URSODEOXYCHOLIC ACID
#509FORMULATIONS OF DEOXYCHOLIC ACID AND SALTS THEREOF
#510Methods and compositions for the treatment of steatosis-associated disorders
#511Antithrombotic composition comprising Nakai extract
#512FARNESOID X RECEPTOR MODULATORS
#513Onapristone extended-release compositions and methods
#514TOPICAL INJECTABLE COMPOSITION
#515Carrier composition for eye drops and pharmaceutical composition including the same
#516METHODS OF ACTIVATING CELLS VIA PTP 1B INHIBITION
#517Neurogenesis stimulant, internal agent, culture medium additive, cell diluent additive, culture medium, and cell diluent
#518Use of glucocorticoid receptor modulators to potentiate checkpoint inhibitors
#519METHODS AND COMPOSITIONS FOR TREATING VARIOUS DISORDERS
#520ENHANCED TRAINED IMMUNITY IN MYELOID CELLS BY SHIP-1 INHIBITION
#521GLUCOCORTICOID INHIBITORS FOR TREATMENT OF PROSTATE CANCER
#522NOVEL USE OF PHYTOSTENONE
#523Compositions of bile acids and phenylbutyrate compounds
#524METHOD FOR THE TREATMENT OF FATTY LIVER DISEASE
#525Oral pharmaceutical composition containing pemetrexed and production method thereof
#526PHARMACEUTICAL COMPOSITIONS AND METHODS
#527USE OF OXYGENATED CHOLESTEROL SULFATES (OCS) TO TREAT INFLAMMATORY SKIN DISEASE AND SKIN LESIONS
#528Treatment for modulating gut microbiota
#529Compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25HC3S) or pharmaceutically acceptable salt thereof and at least one cyclic oligosaccharide
#530METHODS AND COMPOSITIONS FOR THE TREATMENT OF HEPATIC AND METABOLIC DISEASES
#531TREATMENT OF SLEEP APNEA WITH A COMBINATION OF A CARBONIC ANHYDRASE INHIBITOR AND AN ALDOSTERONE ANTAGONIST
#532COMPOSITION FOR SUBCUTANEOUS INJECTION, CONTAINING DEOXYCHOLIC ACID, AND PREPARATION METHOD THEREFOR
#533Compositions and methods for the repair of myelin
#534OXYGENATED CHOLESTEROL SULFATES FOR THERAPY OF DISORDERS CAUSED BY AT LEAST ONE OF ATTENUATED LEPTIN ACTIVITY AND A LIPID STORAGE DISORDER
#535Use of sGC stimulators for the treatment of nonalcoholic steatohepatitis (NASH)
#536Nuclear sulfated oxysterol, potent regulator of lipid homeostasis, for therapy of hypercholesterolemia, hypertriglycerides, fatty liver diseases, and atherosclerosis
#537OXYSTEROLS AND METHODS OF USE THEREOF
#538Spirolactone compounds
#539ANTIFIBROTIC COMPOSITION
#540Treating or preventing adverse liver conditions
#541COMPOSITIONS AND METHODS FOR INHIBITION OF NUCLEAR-PENETRATING ANTIBODIES
#542Ursodeoxycholic acid derivatives as HDAC inhibitors for the treatment of polycystic diseases
#543METHOD FOR TREATING A CANCER ASSOCIATED WITH THE ACTIVATION OF GALECTIN-1
#544METHODS OF DETECTING PROGESTERONE RECEPTOR AND OF DETECTING AN EXPRESSION LEVEL
#545Cholesterol reducing compositions and methods of use thereof
#546USE OF GLUCOCORTICOID RECEPTOR ANTAGONISTS FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS
#547Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis
#548Treatment for primary biliary cholangitis
#549Systems for Removing Air from the Fluid Circuits of a Plasma Processing System
#550Systems for removing air from the fluid circuits of a plasma processing system
#551USE OF PHARMACEUTICAL COMPOSITION IN PREPARING DRUG AGAINST HELICOBACTER PYLORI
#552METHODS FOR TREATING LIVER DISEASES
#553Compounds and methods of promoting myelination
#554COMPOSITION FOR ANTI-AGING
#555CHANNEL MODULATORS
#556DENTAL CARE CANNABIS DEVICE AND USE THEREOF
#557METHODS AND PHARMACEUTICAL COMPOSITIONS FOR REDUCING PERSISTENCE AND EXPRESSION OF EPISOMAL VIRUSES
#558TREATMENT FOR PRIMARY BILIARY CHOLANGITIS
#559Use of cannabinoids in the treatment of a neurodegenerative disease or disorder
#560Combination of a retinoid and an extract of (L.) gaertn
#561TOPICAL COMPOSITIONS COMPRISING A CORTICOSTEROID FOR THE TREATMENT OF PSORIASIS IN PEDIATRIC PATIENTS
#562Non-hormonal steroid modulators of NF-kB for treatment of disease
#563Optimizing Mifepristone Absorption
#564LOW DOSE COMPOSITIONS OF ARAMCHOL SALTS
#565Uses of oxygenated cholesterol sulfates (OCS)
#566Uses of ergosterol combined with gefitinib, preparation methods of liposome and freeze-dried powder thereof
#567OXYSTEROLS AND METHODS OF USE THEREOF
#568Nucleic acid nanocapsules for drug delivery and targeted gene knockdown
#569COMBINATION THERAPIES AND METHODS OF USE THEREOF FOR TREATING CANCER
#570LITHIUM CHOLESTEROL COMPOSITIONS, INCLUDING, BUT NOT LIMITED TO LITHIUM CHOLESTEROL SULFATE COMPOSITIONS, AND METHODS OF TREATMENT FOR ALZHEIMER'S DISEASE AND NEUROLOGICAL DISORDERS
#571Treatment of pneumonia
#572Breath actuated inhaler
#573COMPOSITIONS AND METHODS OF TREATING LIVER DISEASE
#574NANOPARTICLES FOR SUSTAINED OPHTHALMIC DRUG DELIVERY AND METHODS OF USE
#575NEW ROUTE AND ENGINEERING PROTOCOLS FOR ALZHEIMERS DISEASE PREVENTION, TREATMENT AND NEURONAL REBUILDING
#576Methods and pharmaceutical compositions for treating peripheral demyelinating diseases
#577Topical formulations comprising a steroid
#578TREATMENT OF FIBROSIS USING FXR LIGANDS
#579Pharmaceutical compositions and methods of treating cardiovascular diseases
#580Compositions and methods for treating CNS disorders
#581Methods and compositions of bile acids and salts for reduction of fat
#582Compositions and methods for treating ovarian tumors
#583Cultivation of human noroviruses
#584Lipopeptides for Use in Treating Liver Diseases and Cardiovascular Diseases
#585TRITERPENOID-CONTAINING PHARMACEUTICAL COMPOSITION AND USE THEREOF
#586Methods of treating residual lesions of vascular anomalies
#587HORMONAL CONTRACEPTION USING A VAGINAL RING WHICH RELEASES ESTRIOL AND TRIMEGESTONE
#588Methods and products to provide oral nutritional care to subjects with dementia
#589METHODS OF TREATING EOSINOPHILIC ESOPHAGITIS
#590Composition for biological tissue transparency and method for biological tissue transparency using same
#591THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF
#592SHIP INHIBITION TO COMBAT OBESITY
#593AMORPHOUS ONAPRISTONE COMPOSITIONS AND METHODS OF MAKING THE SAME
#594PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CHOLESTEROL GALLSTONE COMPRISING URSODEOXYCHOLIC ACID (UDCA) AND OMEGA-3 FATTY ACID, AND PROCESS FOR PRODUCING THE SAME
#595Inactivating bacteria with electric pulses and antibiotics
#596Lipid-like nanocomplexes and uses thereof
#597Use of CSA compounds to stimulate stem cells and hair growth
#598Composition containing sumo inhibitor and application
#599Liquid depot for non-invasive sustained delivery of agents to the eye
#600OPTHALMIC COMPOSITIONS FOR INHIBITING CLOUDING OF THE OCULAR LENS